.jpg)
.png)
Winter 2018
It is well-established that, compared to men, post-menopausal women enjoy a degree of protection against atherosclerotic cardiovascular disease (ASCVD).1 The rate of ASCVD in post-menopausal women matches or even exceeds that in men.1 In spite of the pre-menopausal protection for women,... more
Evidence in support of statins for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) in women was sparse until recently.1 However, meta-analyses have documented that statins significantly reduce ASCVD event rates in women with elevated baseline risk.2,3,4 Yet a large... more
Hormone replacement therapy (HRT) in post-menopausal women has been a topic of constant debate. HRT with conjugated equine estrogens (CEE) or conjugated equine estrogens with progesterone, was perceived not only to relieve vasomotor symptoms associated with menopause but also to protect... more
Case History Mary is a 40-year-old school teacher who was referred for severe elevation of triglycerides (TGs). She has a past medical history of hypertension, gestational diabetes, pregnancy-induced hypertension, former tobacco use and idiopathic gastroparesis. She was not pregnant at the... more
JK is a 35-year-old female nonsmoker who first presented to clinical lipidology care after developing angina while breastfeeding her first child. A subsequent cardiac catheterization revealed 3-vessel disease, ultimately leading to coronary artery bypass grafting (CABG). Her low-density... more